Agilis

Name

Agilis

Legal name

Agilis Vet Ltd

Website

https://agilis.nz

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Veterinary Animal Health Products

NAICS

Support Activities for Animal Production (1152)

SIC

Agricultural Prod-Livestock & Animal Specialties (200)

akta.pro primary industry

Pharmacy, Biologics & Veterinary Supply Dispensing (Farm Animal) (AFACADAM)

akta.pro secondary industries

Vaccination, Parasite Control & Immunization Programs (AFACADAG), Nutrition & Production Medicine Advisory (Transition Cow, Performance Optimization) (AFACADAI), Veterinary Vaccines (HLAIAEAH)

Keywords

• Animal health products
• Veterinary pharmaceuticals
• Livestock vaccines
• Animal nutrition supplements
• Veterinary distribution

Headquarters

HQ city

Timaru

HQ country

New Zealand

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Animal Health Product Sales: Agilis generates revenue through the supply and marketing of production animal health products to veterinary clinics nationwide. Products span vaccines, nutritional supplements, equipment, and treatments for cattle and sheep health conditions. Revenue is derived from product sales through the veterinary clinic distribution channel.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Agilis Vet Ltd is a New Zealand vet-owned animal health company that supplies and markets production animal health products to veterinary clinics nationwide. Its product range spans vaccines (IBR, BVD, mastitis), nutritional supplements (cobalt, copper, general nutritional drench), application equipment (pump-drenchers, colostrum management systems), and specialty treatments (stress mitigation, calf diarrhea). All products are ACVM-approved and distributed exclusively through veterinary clinics rather than directly to farmers.

Differentiator

Problem solved

Functional benefit

Products and services

• Hiprabovis 3 A multivalent vaccine for cattle covering BVD, IBR (Infectious Bovine Rhinotracheitis), and PI-3, supplied to veterinary clinics for use in New Zealand dairy and beef herds.
• Startvac A mastitis vaccine for dairy cows developed by HIPRA, supplied to veterinary clinics to support udder health and milk quality.
• UBAC A mastitis vaccine for dairy cows targeting gram-positive bacteria including Streptococcus uberis, distributed in New Zealand by Agilis under partnership with HIPRA.
• CobaltSure A cobalt / Vitamin B12 injection supplement for cattle and sheep, used to address cobalt deficiency affecting growth, energy, and immunity in New Zealand livestock.
• CopperSure A copper injection supplement for cattle and sheep, used to address copper deficiency affecting growth, immunity, and productivity.
• RPM A nutritional drench product for sheep and cattle supporting general nutritional supplementation, reproductive performance, and growth.
• SELEKT Pump-Drencher System An equipment system (pump-drencher and collector) for rehydrating cattle, including demonstrations by veterinary experts such as Dr. Toni Johnston on safe technique.
• SELEKT Nutritional Formulae A range of nutritional formulae for cattle covering Fresh Cow, Restore, Off Feed, Antacid, and Glycerol Plus formulations, supporting hydration and recovery.
• SELEKT Charbon Fluide A treatment for calf diarrhea in beef and dairy youngstock, distributed in New Zealand by Agilis under partnership with Nimrod Veterinary Products.
• FerAppease A synthetic mBAS analogue product designed to help reduce stress and support calmer, more productive cattle during management events.
• Perfect Udder Colostrum Management System An all-in-one colostrum management system for early calf development, providing biosecure collection, storage, pasteurisation, freezing, thawing, and feeding of colostrum on dairy farms.

Quantifiable outcome

• Hiprabovis 3 vaccination at dry-off improved empty rates by approximately 4% and 6-week in-calf rates by 6-7% in problem herds with high IBR prevalence (90-100%)
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• HIPRAcoreTechnology or IntegrationHIPRA is a global leader in preventive animal health, offering innovative vaccines and diagnostics with over 50 years of experience and presence in 100+ countries. Agilis distributes HIPRA products in New Zealand including Hiprabovis 3 (BVD/IBR/PI-3 vaccine), Startvac (mastitis vaccine), and UBAC (mastitis vaccine). These products are registered pursuant to the ACVM Act 1997.
• Nimrod Veterinary Products LtdcoreTechnology or IntegrationUK-based company known for SELEKT cattle equipment and nutritional formulae, supporting hydration and recovery in cattle. Agilis distributes the SELEKT range in New Zealand including SELEKT Pump Drencher, SELEKT Collector, SELEKT Nutritional Formulae (Fresh Cow, Restore, Off Feed, Antacid, Glycerol Plus), and SELEKT Charbon Fluide. Nimrod focuses on practical innovation and vet education.

Scale indicators2 records

Recent moves6 records

Expansion highlights3 records

Broad incumbents

• MSD Animal Health: Global animal health division of Merck offering a comprehensive range of vaccines, anti-infectives, and parasiticides for production animals. Comparable to Agilis as a major competitor across virtually every product category Agilis distributes in NZ.
• HIPRA: Global animal health company (50+ years, 100+ countries) focused on preventive animal health including vaccines and diagnostics. Comparable as a major supplier-partner of Agilis; relevant as a benchmark for the broader animal-health competitive landscape and a potential alternative distribution channel if HIPRA chose to go direct in NZ.
• Zoetis: World's largest animal health company with a broad portfolio of vaccines, diagnostics, parasiticides, and nutritionals across production animals. Comparable to Agilis as a competitor in the same product categories sold into NZ vet clinics, though at vastly greater scale and with direct NZ presence.
• Dechra Pharmaceuticals: International animal health company specializing in veterinary pharmaceuticals and specialty products. Comparable to Agilis as a competing distributor of higher-end vet-channel products, particularly in the companion/production-animal overlap.
• Elanco Animal Health: Global animal health leader with cattle, sheep, and swine products. Comparable to Agilis as a competing supplier of vaccines and production-animal health products into the NZ market, with direct local sales infrastructure.
• Virbac: Global animal health company with a substantial production-animal portfolio spanning vaccines, parasiticides, and nutrition. Comparable to Agilis as a multinational competitor whose NZ subsidiary distributes to vet clinics through similar channels.

Regional players

• VetShop NZ / VetEnt Group: NZ veterinary services and supply group combining clinical practice with product distribution. Comparable to Agilis on the supply side, with the added dimension of vertically integrated clinic ownership that may also stock competing product lines.

Direct peers

• AgriHealth New Zealand: NZ-based animal health distribution company supplying veterinary pharmaceuticals and vaccines to NZ livestock and production-animal markets. Directly comparable to Agilis as a domestic distributor relying on international manufacturer partnerships and a field-sales model serving vet clinics.
• Phoenix Pharm Distributors (NZ): NZ veterinary and animal health product distributor serving veterinary clinics across production-animal and companion-animal segments. Comparable to Agilis in channel model (clinic-based distribution), customer base (NZ vets), and product mix of vaccines, parasiticides, and nutritionals.

Emerging players

• Ceva Santé Animale: Global animal health company with growing presence in vaccines and production-animal pharmaceuticals. Comparable to Agilis as both a potential partner (as a source of differentiated products) and a competitor in the same NZ vet-channel categories.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/agilissupplies
• Facebookfacebook.com/Agilisvets
• LinkedInlinkedin.com/company/agilis-vets

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agilis